Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Microbiol ; 63(Pt 11): 1500-1508, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25082946

ABSTRACT

Coagulase-negative staphylococci (CNS), especially Staphylococcus epidermidis and Staphylococcus haemolyticus, have emerged as opportunistic pathogens in immunocompromised patients and those with indwelling medical devices. In this study, CNS recovered from patients with bloodstream infections (BSIs) or prosthetic-device-associated infections (PDAIs) were compared in terms of biofilm formation, antimicrobial resistance, clonal distribution, and carriage of adhesin and toxin genes. A total of 226 CNS isolates (168 S. epidermidis and 58 S. haemolyticus) recovered from hospital inpatients with BSIs (100 isolates) or PDAIs (126 isolates) were tested for biofilm formation, antimicrobial susceptibility, and mecA, ica operon, adhesin (aap, bap, fnbA, atlE, fbe) and toxin (tst, sea, sec) genes. The selected CNS were classified into pulsotypes by PFGE and assigned to sequence types by multilocus sequence typing. In total, 106/226 isolates (46.9%) produced biofilm, whereas 150 (66.4%) carried the ica operon. Most isolates carried mecA and were multidrug resistant (90.7%). CNS recovered from BSIs were significantly more likely to produce biofilm (P=0.003), be resistant to antimicrobials and carry mecA (P<0.001), as compared with isolates derived from PDAIs. CNS from PDAIs were more likely to carry the aap and bap genes (P=0.006 and P=0.045, respectively). No significant differences in the carriage of toxin genes were identified (P>0.05). Although PFGE revealed genetic diversity, especially among S. epidermidis, analysis of representative strains from the main PFGE types by multilocus sequence typing revealed three major clones (ST2, ST5 and ST16). A clonal relationship was found with respect to antimicrobial susceptibility and ica and aap gene carriage, reinforcing the premise of clonal expansion in hospital settings. The results of this study suggest that the pathogenesis of BSIs is associated with biofilm formation and high-level antimicrobial resistance, whereas PDAIs are related to the adhesion capabilities of S. epidermidis and S. haemolyticus strains.


Subject(s)
Bacteremia/microbiology , Biofilms/growth & development , Prosthesis-Related Infections/microbiology , Staphylococcal Infections/microbiology , Staphylococcus/enzymology , Staphylococcus/physiology , Adhesins, Bacterial/genetics , Adhesins, Bacterial/metabolism , Anti-Bacterial Agents/pharmacology , Bacterial Toxins/genetics , Bacterial Toxins/metabolism , Coagulase/genetics , Coagulase/metabolism , Drug Resistance, Bacterial , Gene Expression Regulation, Bacterial , Humans , Microbial Sensitivity Tests , Staphylococcus/drug effects , Staphylococcus/genetics
2.
Chest ; 143(1): 152-157, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22911476

ABSTRACT

BACKGROUND: Protracted bacterial bronchitis is a major cause of persistent cough in childhood. The organisms most commonly isolated are nontypable Haemophilus influenzae and Streptococcus pneumoniae . There are no studies addressing typing of these organisms when recovered from the lower airways. METHODS: Isolates of these two organisms (identified in BAL samples from children undergoing routine investigation of a chronic cough thought to be attributable to a protracted bacterial bronchitis) were subject to typing. Samples were collected in Sheffield, England, and Athens, Greece. The majority of the children from Sheffield had received pneumococcal-conjugate vaccines 7 or 13 (PCV-7 or PCV-13) conjugate vaccine but only a minority of Greek children had received PCV-7. RESULTS: All 18 S pneumoniae isolates from Greek BAL samples are serotypes contained in PCV-13 while 10 are contained in PCV-7. In contrast, 28 of the 39 samples from Sheffield contained serotypes that are not included in PCV-13. All 26 of the nontypable H influenzae samples obtained in Sheffield produced distinct multilocus variable-number tandem repeat analysis profiles. There was a significant difference between children from Athens and Sheffield in the distribution of serotypes contained or not contained in the pneumococcal vaccine ( P = .04). More specifically, immunization with pneumococcal vaccine was related with isolation of S pneumoniae serotypes not included in the vaccine (OR, 0.021; CI, 0.003-0.115; P < .001). CONCLUSIONS: The data suggest that both vaccine and nonvaccine S pneumoniae serotypes may play a role in protracted bacterial bronchitis and provide some hints that serotype replacement may occur in response to the introduction of conjugate vaccines.


Subject(s)
Bronchitis/microbiology , Haemophilus Vaccines/therapeutic use , Haemophilus influenzae/classification , Pneumococcal Vaccines/therapeutic use , Streptococcus pneumoniae/classification , Adolescent , Bronchitis/prevention & control , Bronchoalveolar Lavage Fluid/microbiology , Child , Child, Preschool , Female , Genotyping Techniques , Haemophilus Infections/microbiology , Haemophilus Infections/prevention & control , Humans , Infant , Male , Pneumococcal Infections/microbiology , Pneumococcal Infections/prevention & control , Polymerase Chain Reaction , Serotyping , Vaccines, Conjugate/therapeutic use
3.
Antimicrob Agents Chemother ; 55(6): 3025-30, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21444701

ABSTRACT

In this study, the first such study in Greece, we used polyphasic identification combined with antifungal susceptibility study to analyze Aspergillus clinical isolates comprising 102 common and rare members of sections Fumigati, Flavi, Terrei, Nidulantes, Nigri, Circumdati, Versicolores, and Usti. High amphotericin B MICs (>2 µg/ml) were found for 17.6% of strains. Itraconazole, posaconazole, and voriconazole MICs of >4 µg/ml were shown in 1%, 5%, and 0% of the isolates, respectively. Anidulafungin, micafungin, and caspofungin minimum effective concentrations (MECs) of ≥2 µg/ml were correspondingly recorded for 4%, 9%, and 33%, respectively, of the strains.


Subject(s)
Antifungal Agents/pharmacology , Aspergillus/drug effects , Drug Resistance, Fungal , Greece , Humans , Immunocompromised Host , Microbial Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...